ESR1 and neoplasm: Beyond mutations and methylation, ER expression in the CTCs of 60 patients with metastatic breast cancer with ER-positive primary tumours at initial cancer diagnosis was evaluated in 109 longitudinal blood samples that were prospectively collected and analyzed using the CellSearch® system.